No reaction from the market today from the release of this interim data. It seems this result was priced in already. Nothing more could have been expected from the results so far though since the trial is still blinded, correct? Dr Glass gave the impression that the results were significant due to the safety profile demonstrated validates the titration methodology used and the safety of the drug for the inhalation programs and the smoking cessation trial also. Is that what others understood from it also?
Hopefully results from the smoking cessation trial will be the share price catalyst we're hoping for
IVX Price at posting:
7.9¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)